Anne-Laure Simonet-Lamm

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The selection of patients for phase I cancer trials remains challenging. Patients who dropout of the trial before completion need to be replaced and this can result in significant delays to trial completion. The objective of this study was to identify patients enrolled in phase I oncology trials who were unable to complete the minimum evaluation period of(More)
  • 1